Successful coronavirus vaccine trials provide new hope in fight against the disease
Preliminary results show a 94.5% effectiveness rate for Moderna's coronavirus vaccine in Phase 3 trials. The company expects to request emergency use authorization from the FDA within a few weeks. Dr. Jon LaPook reports.